Literature DB >> 33315666

Epithelioid Hemangioma of Vertebra Mimicking Metastasis on FDG PET/CT in a Patient With Renal Cell Cancer.

Fumi Yanagisawa1, Yasuo Amano1, Yuko Omori1, Ryo Takagi, Xiaoyan Tang2.   

Abstract

ABSTRACT: Vertebral epithelioid hemangioma is a rare vascular tumor composed of the many vessels lined by distinct epithelioid endothelial cells. We present the case of a patient with renal cell cancer (RCC) and suspicious vertebral metastasis presenting with back pain, who was later found to have epithelioid hemangioma. FDG PET/CT demonstrated uptake of FDG not only in RCC, but also in the sixth thoracic vertebral body. The SUVmax of the vertebra was more than twice as high as RCC. This report indicates importance of quantitative assessment of FDG uptake, as well as combined use of MRI.
Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33315666      PMCID: PMC7774811          DOI: 10.1097/RLU.0000000000003428

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   10.782


A 61-year-old man with back pain was admitted to our hospital. CT reveals a large renal cell carcinoma (RCC). FDG PET/CT was examined for staging RCC. FDG MIP (A, arrows) and fusion images (B, C) demonstrate high uptake of FDG not only in RCC but also in the thoracic vertebral body, indicating vertebral metastasis. Transverse CT (D) shows the osteolytic lesion with a cortical disruption but no extraosseus expansion. The SUVmax of the vertebral tumor is 11.4, whereas that of RCC is 4.5. On MRI, the vertebral lesion shows isointensity relative to the muscle on T1-weighted images and hyperintensity accompanying vascular flow voids on T2-weighted images (A, arrows). Histological diagnosis was derived from the biopsy of the lesion. Hematoxylin-eosin stain of the specimen shows a vascular proliferation composed predominantly of well-formed capillary channels lined by epithelioid endothelial cells that appeared to protrude into the vascular lumina (B). Immunohistochemical staining reveals that the endothelial cells were positive for CD31 (C). The diagnosis of an epithelioid hemangioma (EH) of the bone is made, and RCC is a clear cell cancer. Considering a history of large RCC and the osteolytic appearances and FDG uptake of an EH in this case, EH can be clinically and radiologically confused with a malignant bone tumor, especially vertebral metastasis.[1] Epithelioid hemangioma is a rare intermediate vascular tumor with a ubiquitous location, including soft tissue and bone.[2-5] The World Health Organization recommends separating EH from conventional hemangiomas because of its local aggression and high recurrence.[6,7] There are several reports of high FDG accumulation of the vertebral hemangiomas.[8,9] To our knowledge, only one report showed high uptakes of FDG in EHs of skeletal lesions.[10] The FDG uptake in EH can be caused by its characteristics of high cellularity and local aggression.[10] In this case, the SUVmax of the vertebra was more than twice as high as RCC. The uptake was too high for metastasis of RCC: the uptake of RCC was relatively low because of the lower glucose metabolism.[11] In addition, MRI indicated the vascular lesion showing high intensity and flow voids on T2-weighted images. This case highlights the potential to misdiagnose vertebral EH as metastasis from RCC on FDG PET/CT. Nonetheless, the careful interpretation of SUVmax and MRI can help differentiating the lesion from metastasis from RCC, even if we could not make the diagnosis of EH.
  10 in total

1.  [WHO classification of tumours of soft tissue and bone 2013: the main changes compared to the 3rd edition].

Authors:  Iva Zambo; Karel Veselý
Journal:  Cesk Patol       Date:  2014-04

2.  Epithelioid hemangioma of bone and soft tissue: a reappraisal of a controversial entity.

Authors:  Costantino Errani; Lei Zhang; David M Panicek; John H Healey; Cristina R Antonescu
Journal:  Clin Orthop Relat Res       Date:  2011-09-24       Impact factor: 4.176

3.  ZFP36-FOSB fusion defines a subset of epithelioid hemangioma with atypical features.

Authors:  Cristina R Antonescu; Hsiao-Wei Chen; Lei Zhang; Yun-Shao Sung; David Panicek; Narasimhan P Agaram; Brendan C Dickson; Thomas Krausz; Christopher D Fletcher
Journal:  Genes Chromosomes Cancer       Date:  2014-07-18       Impact factor: 5.006

Review 4.  Epithelioid Hemangioma of the Thoracic Spine: A Case Report and Review of the Literature.

Authors:  Eijiro Okada; Morio Matsumoto; Mitsuhiro Nishida; Takahito Iga; Midori Morishita; Masaki Tezuka; Kiyoshi Mukai; Eisuke Kobayashi; Kota Watanabe
Journal:  J Spinal Cord Med       Date:  2017-10-25       Impact factor: 1.985

Review 5.  Epithelioid hemangioma of bone: a report of two special cases and a literature review.

Authors:  Qin Zhou; Liangji Lu; YanBiao Fu; KeWei Xiang; Leiming Xu
Journal:  Skeletal Radiol       Date:  2016-09-22       Impact factor: 2.199

6.  Epithelioid hemangioma of bone revisited: a study of 50 cases.

Authors:  G Petur Nielsen; Amitabh Srivastava; Susan Kattapuram; Vikram Deshpande; John X O'Connell; Chas D Mangham; Andrew E Rosenberg
Journal:  Am J Surg Pathol       Date:  2009-02       Impact factor: 6.394

Review 7.  Sarcoma classification: an update based on the 2013 World Health Organization Classification of Tumors of Soft Tissue and Bone.

Authors:  Leona A Doyle
Journal:  Cancer       Date:  2014-03-19       Impact factor: 6.860

8.  Preoperative evaluation of renal cell carcinoma by using 18F-FDG PET/CT.

Authors:  Miwako Takahashi; Haruki Kume; Keitaro Koyama; Tohru Nakagawa; Tetsuya Fujimura; Teppei Morikawa; Masashi Fukayama; Yukio Homma; Kuni Ohtomo; Toshimitsu Momose
Journal:  Clin Nucl Med       Date:  2015-12       Impact factor: 7.794

9.  Hemangioma of the rib showing a relatively high 18F-FDG uptake: a case report with a literature review.

Authors:  Takahide Itabashi; Makoto Emori; Yoshinori Terashima; Tadashi Hasegawa; Junya Shimizu; Satoshi Nagoya; Toshihiko Yamashita
Journal:  Acta Radiol Open       Date:  2017-09-07

10.  Bisphosphonates as a therapeutic choice for multifocal epithelioid hemangioma of bone: A case report.

Authors:  Lizhi Tang; Guangwen Chen; Qin Wang; Jobin John; Chunyan Lu
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.